ANI Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 2.66 M | $210.12 M | 4.43% | 13.26% |
| VANGUARD GROUP INC | 01/29/2026 | 1.31 M | $103.02 M | 2.16% | 6.50% |
| STATE STREET CORP | 02/13/2026 | 727.20 K | $57.41 M | 2.18% | 3.62% |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 02/11/2026 | 590.14 K | $46.59 M | -6.42% | 2.94% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 539.67 K | $42.60 M | 727.14% | 2.69% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 487.67 K | $38.50 M | -3.51% | 2.43% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 486.24 K | $38.38 M | 42.91% | 2.42% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 481.44 K | $38.00 M | 51.63% | 2.40% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 477.68 K | $37.71 M | 6.15% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 477.27 K | $37.68 M | 4.20% | 2.38% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 473.21 K | $37.35 M | 31.38% | 2.36% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 400.28 K | $31.60 M | 5.61% | 1.99% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 392.58 K | $30.99 M | 55.43% | 1.96% |
| NUVEEN, LLC | 02/12/2026 | 387.10 K | $30.56 M | -2.02% | 1.93% |
| RANGER INVESTMENT MANAGEMENT, L.P. | 02/13/2026 | 362.38 K | $28.61 M | 33.55% | 1.81% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 316.69 K | $25.00 M | -9.17% | 1.58% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 314.40 K | $24.82 M | 15.21% | 1.57% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 299.28 K | $23.63 M | 100.00% | 1.49% |
| MORGAN STANLEY | 02/13/2026 | 281.43 K | $22.22 M | 21.29% | 1.40% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 269.90 K | $21.31 M | -7.52% | 1.34% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 253.54 K | $20.01 M | 19.03% | 1.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 251.63 K | $19.86 M | 6.78% | 1.25% |
| JPMORGAN CHASE & CO | 02/11/2026 | 244.67 K | $19.31 M | 89.53% | 1.22% |
| ABRDN PLC | 01/16/2026 | 240.79 K | $19.01 M | -10.71% | 1.20% |
| NOMURA HOLDINGS INC | 02/17/2026 | 223.94 K | $17.68 M | 14.53% | 1.12% |
| ROYAL BANK OF CANADA | 02/17/2026 | 221.30 K | $17.47 M | 5.03% | 1.10% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 219.36 K | $17.32 M | 12.93% | 1.09% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 217.88 K | $17.20 M | 14.55% | 1.09% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 213.80 K | $16.88 M | 12.30% | 1.07% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 205.09 K | $16.19 M | -28.33% | 1.02% |
| MIZUHO MARKETS AMERICAS LLC | 02/06/2026 | 201.99 K | $15.95 M | 11.86% | 1.01% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 200.00 K | $15.79 M | 100.00% | 1.00% |
| APIS CAPITAL ADVISORS, LLC | 02/17/2026 | 196.00 K | $15.47 M | 19.51% | 0.98% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 193.57 K | $15.28 M | -14.93% | 0.96% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 192.01 K | $15.16 M | 780.76% | 0.96% |
| INVESCO LTD. | 02/19/2026 | 189.84 K | $14.99 M | 26.00% | 0.95% |
| OBERWEIS ASSET MANAGEMENT INC/ | 02/17/2026 | 188.83 K | $14.91 M | 35.95% | 0.94% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 181.15 K | $14.30 M | 236.82% | 0.90% |
| NORTHERN TRUST CORP | 02/17/2026 | 176.81 K | $13.96 M | -6.25% | 0.88% |
| CITIGROUP INC | 02/13/2026 | 171.97 K | $13.58 M | 65.39% | 0.86% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 168.83 K | $13.33 M | -1.93% | 0.84% |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 01/28/2026 | 151.28 K | $11.94 M | -1.06% | 0.75% |
| UBS GROUP AG | 01/29/2026 | 150.78 K | $11.90 M | -74.44% | 0.75% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 145.00 K | $11.45 M | 100.00% | 0.72% |
| FREESTONE GROVE PARTNERS LP | 02/17/2026 | 141.11 K | $11.14 M | 359.88% | 0.70% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/09/2026 | 137.39 K | $10.86 M | 2,058.93% | 0.68% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 126.48 K | $9.98 M | 34.41% | 0.63% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 121.21 K | $9.57 M | -69.63% | 0.60% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 117.31 K | $9.26 M | -45.77% | 0.58% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 112.64 K | $8.89 M | -3.12% | 0.56% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ANI Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 405 institutional investors and hedge funds held shares of ANI Pharmaceuticals Inc. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 531,190
UBS Group AG: 497,702
Nuveen, LLC: 402,357
Global Alpha Capital Management Ltd.: 361,240
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 327,276
Invesco Ltd.: 324,349
105.44% of ANI Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 26.95 M shares in the last 24 months. This purchase volume represents approximately $2.02 B in transactions.